CADL Stock-Based Compensation

Candel Therapeutics Inc · Stock-Based Compensation

CADL logo

CADL Stock-Based Compensation

Latest reported$6.76M
CADL TTM Stock-Based Comp ($2.11M → $6.76M)
High-resolution chart · PNG

CADL stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Candel Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
6,763,000
4,955,000
3,817,000
3,771,000
3,792,000
4,583,000
5,312,000
5,007,000
4,509,000
3,401,000
3,091,000
2,786,000
2,843,000
2,548,000
2,307,000
1,227,000
2,393,000
3,024,000
2,963,000
5,162,000
3,336,000
2,570,000
2,107,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.